Published in Immunotherapy Weekly, June 28th, 2006
"The Meropenem Yearly Susceptibility Test Information Collection Program is a global, longitudinal resistance surveillance network of more than 100 medical centers worldwide monitoring the susceptibility of bacterial pathogens to carbapenems and other broad-spectrum agents.
"Between 1999 and 2004, a total of 10-16 U.S. medical centers referred up to 200 nonduplicate isolates from clinical infections to a central processing laboratory," wrote investigators in England.
According to the authors, "Over this 6-year period, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.